Publications by authors named "M H Ohlmeyer"

The reactivation of heterotrimeric protein phosphatase 2A (PP2A) through small molecule activators is of interest to therapeutic intervention due to its dysregulation, which is linked to chronic conditions. This study focuses on the PP2A scaffold subunit PR65 and a small molecule activator, ATUX-8385, designed to bind directly to this subunit. Using a label-free single-molecule approach with nanoaperture optical tweezers (NOT), we quantify its binding, obtaining a dissociation constant of 13.

View Article and Find Full Text PDF

Over the recent past, tools have been developed to asses people's connection to and attitudes towards nature due to increasing interest in this topic in society and research. We translated one such questionnaire, the Nature Relatedness Scale, consisting of three subscales (NR-Self, NR-Perspective, NR-Experience) to German. We collected 251 data sets and performed a confirmatory factor analysis, followed by an exploratory factor analysis.

View Article and Find Full Text PDF
Article Synopsis
  • Neuroblastoma (NB) is a highly dangerous pediatric cancer, and current treatments for high-risk patients are not very effective, prompting research into new therapies.
  • Two new PP2A activators, ATUX-3364 and ATUX-8385, were tested in various NB cell lines and in animal models, revealing that they can activate PP2A and significantly reduce cancer cell viability, growth, and movement.
  • The study found that these activators not only hinder tumor growth in live models but also impact MYCN protein levels, suggesting potential for developing targeted therapies against MYCN in treating neuroblastoma.
View Article and Find Full Text PDF

Leptomeningeal dissemination (LMD) is the primary cause of treatment failure in children with group 3 medulloblastoma (MB). Building on our previous work on protein phosphatase 2A (PP2A) activation in MB, here we present preclinical and molecular data on the effects of two novel classes of PP2A activators on disease processes of LMD in group 3 MB. The PP2A activators used in this study are ATUX-6156 and ATUX-6954 (diarylmethylcycloamine sulfonylureas), and ATUX-1215 and ATUX-5800 (diarylmethyl-4-aminotetrahydropyran-sulfonamides).

View Article and Find Full Text PDF

Pinewood, increasingly used in construction and interior fittings, emits high amounts of volatile organic compounds (VOCs), which tend to accumulate in indoor air. Whether indoor VOCs affect the development of atopic dermatitis (AD) is a matter of debate. We aimed to evaluate the effects of pinewood VOCs on the development of AD-like inflammatory phenotype and linked microbiome alterations, both hallmarks of AD.

View Article and Find Full Text PDF